[HTML][HTML] Assessing characteristics of RNA amplification methods for single cell RNA sequencing

HR Dueck, R Ai, A Camarena, B Ding, R Dominguez… - BMC genomics, 2016 - Springer
Background Recently, measurement of RNA at single cell resolution has yielded surprising
insights. Methods for single-cell RNA sequencing (scRNA-seq) have received considerable …

[HTML][HTML] Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period

…, AV Bennett, D Schrag, GL Mazza, AC Dueck - Quality of Life …, 2023 - Springer
… -hour recall in addition to the standard 7-day recall period. In this analysis, we examined
test–retest reliability for two consecutive days of reporting with a 24-hour … a 24-hour recall period …

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 …

…, M Bates, JM Weidler, W Huang, A Dueck… - Clinical Cancer …, 2018 - AACR
… total HER2 level was significantly associated with longer (OS; HR, 0.33; P = 0.002) and
decreasing p95HER2 level was significantly associated with longer OS (HR, 4.2; P = 0.01). Total …

[HTML][HTML] Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2–positive breast cancer: results from the randomized phase III adjuvant …

…, J Baselga, E De Azambuja, AC Dueck… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
… 850 events required for 80% power to detect a hazard ratio (HR) of 0.8 for L+ T versus T. …
048), and a 4% reduction was observed with T→ L compared with T (HR, 0.96; 97.5% CI, 0.80 …

Assessing the measurement transfer function of single-cell RNA sequencing

HR Dueck, R Ai, A Camarena, B Ding, R Dominguez… - bioRxiv, 2016 - biorxiv.org
Recently, measurement of RNA at single cell resolution has yielded surprising insights.
Methods for single-cell RNA sequencing (scRNA-seq) have received considerable attention, but …

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone …

…, AP Holmes, J Baselga, E De Azambuja, AC Dueck… - 2014 - ascopubs.org
… T comparison would provide 80% power to detect a true hazard ratio (HR) of 0.80 with
experiment-wide alpha=0.05. The current analysis was planned to occur either after observing …

[HTML][HTML] Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer

…, AM Deal, LJ Rogak, C Fuh, JA Greer, AC Dueck… - Annals of …, 2020 - Elsevier
… However, older patients did not experience significantly lower risk of ER visits (HR = 0.90,
P = 0.613) or improved survival (HR = 1.06, P = 0.753) with the intervention. We found no …

LBA12 Pallas: a randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2-early breast cancer

…, D Fumagalli, KP Theall, C Fesl, A Dueck - Annals of …, 2020 - annalsofoncology.org
Background Palbociclib (P) added to endocrine therapy (ET) improves progression-free
survival in hormone receptor positive (HR+)/HER-2 negative (HER2-) metastatic breast cancer. …

In vivo transport of calcium from healed Thiry-Vella fistulas in dogs

CF Cramer, J Dueck - American Journal of Physiology …, 1962 - journals.physiology.org
… The dogs were fasted 42 hr and then anesthetized … The aqueous solution of calcium lactate
at pH 6.5-7.0 was pumped, by a constant-speed finger-type pump at the rate of 22o/hr, into …

Limits to maximal performance in individuals with spinal cord injury

MTE Hopman, C Dueck, M Monroe… - … journal of sports …, 1998 - thieme-connect.com
… ), peak heart rate (HR peak) and maximal systolic blood pressure were significantly lower
in TP compared to PR for all conditions. A significant decrease in HR peak for PR. and a …